Notoginsenoside R1 alleviates high glucose-evoked damage in RSC96 cells through down-regulation of miR-503
- Type
- Expression of concern
- Notice date
- 2/3/2022 0:00
- Journal
- Artificial Cells, Nanomedicine, and Biotechnology
- Publisher
- Taylor and Francis
- Notice DOI
- 10.1080/21691401.2021.2003045
- Original paper DOI
- 10.1080/21691401.2019.1671434